Drug Trial Radar · NCT05957107
Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis
Last checked: Nov 20, 2026Latest source record: Jul 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
181
Actual
Start
May 26, 2022
Primary completion
Jun 2, 2023
Study completion Jun 2, 2023
Sponsor
- Lead sponsor
- Beijing VDJBio Co., LTD.Industry
- Sponsor type
- Industry
- First posted
- Jul 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo and tocilizumab controlled phase II trial in RA patients to evaluate the initial efficacy, safety, pharmacokinetic, pharmacodynamic characteristics, and immunogenicity of VDJ001 in RA patients.
Conditions
- Rheumatoid Arthritis
Interventions
Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody InjectionBiological
The drug was administered once every 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients who achieved ACR20 at week 12.Time frame: 12 weeks
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Baoji Central Hospital
Baoji, China
Beijing Hospital
Beijing, China
The First Affiliated Hospital of Bengbu Medical College
Bengbu, China
Chenzhou First People's Hospital
Chenzhou, China
Pingxiang People's Hospital
Jiangxi, China
Jilin Province People's Hospital
Jilin City, China
Affiliated Hospital of North Sichuan Medical College
Nanchong, China
Drum Tower Hospital Affiliated to Nanjing University Medical School
Nanjing, China
Puyang Oilfield General Hospital
Pujiang, China
Qilu Hospital of Shandong University
Shandong, China
Peking University Shenzhen Hospital
Shenzhen, China
People's Hospital of Xinjiang Uygur Autonomous Region
Xinjiang, China
Zaozhuang Municipal Hospital
Zaozhuang, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.